Trade Name Albenza
Orphan Indication Neurocysticercosis due to Taenia solium as: 1) chemotherapy of parenchymal, subarachnoidal and racemose (cysts in spinal fluid) neurocysticercosis in symptomatic cases and 2) prophylaxis of epilepsy and other sequelae in asymptomatic neurocysticercosis
USA Market Approval USA
USA Designation Date 1996-01-18 00:00:00
Sponsor Amedra Pharmaceuticals LLC;2 Walnut Grove Drive, Suite 190;Horsham, Pennsylvania, 19044